May 13, 2021

New Consensus Guidelines for Botulinum Toxin Therapy of Dystonia and Spasticity

Professor Dirk Dressler Botulinum toxin (BT) therapy is based on applying appropriate doses of BT into an appropriate selection of muscles. Both, the list of target muscles together with their BT doses, constitute the dosing scheme. Developing the dosing scheme for each patient individually requires considerable experience and makes BT therapy what some people might call…

Show this Post ›
March 22, 2021

Medtronic Recieves CE Mark Approval for SenSightTM Directinoal Lead System for DBS Therapy

Press Release from Medtronic March 22, 2021 This First-of-its-Kind Directional Lead Combines the Benefits of Directionality with the Power of Sensing DUBLIN, March 22, 2021 /PRNewswire/ — Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the CE (Conformité Européenne) Mark for the SenSight™ directional lead system for Deep Brain Stimulation (DBS) therapy…

Show this Post ›
December 10, 2020

New Artificial Intelligence Platform Diagnoses Focal Dystonia with High Accuracy in Less Than One Second

This article was published in Dystonia Dialogue, Winter issue 2020 of DMRF (Dystonia Medical Research Foundation in the US), and we are happy to share it with our readers. The article is about the recently published research using a new diagnostic tool diagnosing dystonia from MRI. Researchers at Massachusetts Eye and Ear in Boston have…

Show this Post ›
November 1, 2020

DBS in Dystonia patients: An interview featuring Profs. Ferreira and Coelho from University Hospital of Santa Maria, in Lisbon.

The following article makes reference to certain companies and their products and any opinions expressed should not be taken to be the views of Dystonia Europe or its members. The articles are written by respected authors and are provided for the information of  Dystonia Europe News readers. Dystonia is a heterogenous disease, which dramatically affects the…

Show this Post ›